{
  "Johnson & Johnson": {
    "2021": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 5 - Corporate Governance and Management": {
          "ITEMS": {
            "Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers": {
              "content": "On October 12, 2021, Johnson & Johnson (the “Company”) issued a press release announcing that Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, has elected to retire, effective December 31, 2021. A copy of the Company's press release, dated October 12, 2021, is contained in Exhibit 99.1 to this Report.",
              "subsections": {}
            }
          }
        },
        "Section 9 - Financial Statements and Exhibits": {
          "ITEMS": {
            "Item 9.01 - Financial Statements and Exhibits": {
              "content": "(d) Exhibits.",
              "subsections": {
                "Exhibits List": "Exhibit No. 99.1: Press Release dated October 12, 2021. Exhibit No. 104: The cover page from this Current Report on Form 8-K, formatted in Inline XBRL."
              }
            }
          }
        }
      }
    }
  }
}